Steven Valiquette
Stock Analyst at Mizuho Securities
(1.11)
# 3,557
Out of 4,382 analysts
706
Total ratings
51%
Success rate
-0.7%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintained: Buy | $295 → $270 | $172.61 | +56.42% | 10 | Jun 3, 2026 | |
| DOCS Doximity | Maintained: Hold | $34 → $26 | $20.59 | +26.27% | 8 | May 14, 2026 | |
| XRAY DENTSPLY SIRONA | Maintained: Hold | $16 → $14 | $10.00 | +40.00% | 31 | May 6, 2026 | |
| HSIC Henry Schein | Maintained: Hold | $88 → $82 | $77.45 | +5.87% | 23 | May 6, 2026 | |
| ALGN Align Technology | Maintained: Buy | $215 → $220 | $167.74 | +31.16% | 34 | Apr 30, 2026 | |
| PHR Phreesia | Maintained: Buy | $22 → $19 | $9.54 | +99.16% | 4 | Mar 24, 2026 | |
| LFMD LifeMD | Upgraded: Buy | $6 → $8 | $4.89 | +63.60% | 8 | Mar 16, 2026 | |
| GDRX GoodRx Holdings | Maintained: Hold | $4 → $3 | $2.65 | +13.21% | 7 | Feb 27, 2026 | |
| TDOC Teladoc Health | Maintained: Hold | $10 → $6 | $7.05 | -14.89% | 23 | Feb 26, 2026 | |
| MDLN Medline | Maintained: Buy | $48 → $53 | $33.61 | +57.69% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $6 | $5.22 | +14.94% | 5 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $235 | $205.71 | +14.24% | 33 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $885 | $775.66 | +14.10% | 45 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $27 | $23.10 | +16.88% | 9 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $42 | $20.00 | +110.00% | 6 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $85 → $100 | $81.01 | +23.44% | 5 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 → $380 | $275.04 | +38.16% | 36 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 | $88.67 | +42.10% | 7 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $585 | $350.08 | n/a | 12 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $10 | $4.98 | n/a | 16 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $95.93 | n/a | 27 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $5 | $34.38 | n/a | 10 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $12.34 | n/a | 13 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $13 | $18.46 | n/a | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $24 | $19.65 | n/a | 6 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $575 | $415.53 | n/a | 22 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $20 | $37.97 | n/a | 18 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $55 | $82.02 | n/a | 20 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $31 | $44.47 | n/a | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $355 | $289.48 | n/a | 19 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $92 | $206.93 | n/a | 22 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $105 | $162.06 | n/a | 20 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $63 → $61 | $104.01 | n/a | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $300 | $372.13 | n/a | 16 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $375 | $190.86 | n/a | 20 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $142 | $145.17 | n/a | 18 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $32 | $19.79 | n/a | 16 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $565 | $399.47 | n/a | 21 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $86 | $62.33 | n/a | 11 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $1 → $2 | $25.84 | n/a | 8 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $35 → $34 | $36.05 | n/a | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $30 | $0.674 | n/a | 6 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $16 | $1.73 | n/a | 10 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $5 | $0.8792 | n/a | 6 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $26 → $19 | $7.30 | n/a | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $15 | $6.68 | n/a | 3 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $6 → $10 | $2.74 | n/a | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 → $33 | $2.70 | n/a | 15 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $135 | $192.16 | n/a | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.11 | n/a | 1 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $19 → $14 | $5.00 | n/a | 3 | May 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $200.29 | n/a | 2 | Mar 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $49 | $181.34 | n/a | 1 | Sep 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $149.45 | n/a | 1 | Sep 17, 2013 |
Veeva Systems
Jun 3, 2026
Maintained: Buy
Price Target: $295 → $270
Current: $172.61
Upside: +56.42%
Doximity
May 14, 2026
Maintained: Hold
Price Target: $34 → $26
Current: $20.59
Upside: +26.27%
DENTSPLY SIRONA
May 6, 2026
Maintained: Hold
Price Target: $16 → $14
Current: $10.00
Upside: +40.00%
Henry Schein
May 6, 2026
Maintained: Hold
Price Target: $88 → $82
Current: $77.45
Upside: +5.87%
Align Technology
Apr 30, 2026
Maintained: Buy
Price Target: $215 → $220
Current: $167.74
Upside: +31.16%
Phreesia
Mar 24, 2026
Maintained: Buy
Price Target: $22 → $19
Current: $9.54
Upside: +99.16%
LifeMD
Mar 16, 2026
Upgraded: Buy
Price Target: $6 → $8
Current: $4.89
Upside: +63.60%
GoodRx Holdings
Feb 27, 2026
Maintained: Hold
Price Target: $4 → $3
Current: $2.65
Upside: +13.21%
Teladoc Health
Feb 26, 2026
Maintained: Hold
Price Target: $10 → $6
Current: $7.05
Upside: -14.89%
Medline
Feb 26, 2026
Maintained: Buy
Price Target: $48 → $53
Current: $33.61
Upside: +57.69%
Feb 20, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $5.22
Upside: +14.94%
Feb 10, 2026
Maintained: Buy
Price Target: $235
Current: $205.71
Upside: +14.24%
Feb 10, 2026
Maintained: Hold
Price Target: $885
Current: $775.66
Upside: +14.10%
Feb 10, 2026
Maintained: Hold
Price Target: $24 → $27
Current: $23.10
Upside: +16.88%
Feb 4, 2026
Maintained: Buy
Price Target: $50 → $42
Current: $20.00
Upside: +110.00%
Jan 20, 2026
Upgraded: Buy
Price Target: $85 → $100
Current: $81.01
Upside: +23.44%
Nov 6, 2025
Maintained: Buy
Price Target: $340 → $380
Current: $275.04
Upside: +38.16%
Jul 2, 2025
Reiterated: Buy
Price Target: $126
Current: $88.67
Upside: +42.10%
Aug 23, 2023
Rated: Buy
Price Target: $585
Current: $350.08
Upside: n/a
Aug 21, 2023
Rated: Buy
Price Target: $12 → $10
Current: $4.98
Upside: n/a
Aug 17, 2023
Rated: Buy
Price Target: $86
Current: $95.93
Upside: n/a
Aug 14, 2023
Rated: Sell
Price Target: $5
Current: $34.38
Upside: n/a
Aug 10, 2023
Maintained: Buy
Price Target: $7
Current: $12.34
Upside: n/a
Aug 10, 2023
Rated: Hold
Price Target: $13
Current: $18.46
Upside: n/a
Aug 10, 2023
Rated: Buy
Price Target: $25 → $24
Current: $19.65
Upside: n/a
Aug 8, 2023
Rated: Buy
Price Target: $575
Current: $415.53
Upside: n/a
Aug 8, 2023
Rated: Hold
Price Target: $20
Current: $37.97
Upside: n/a
Aug 7, 2023
Rated: Buy
Price Target: $55
Current: $82.02
Upside: n/a
Aug 4, 2023
Rated: Hold
Price Target: $31
Current: $44.47
Upside: n/a
Aug 3, 2023
Reiterated: Buy
Price Target: $355
Current: $289.48
Upside: n/a
Aug 1, 2023
Reiterated: Buy
Price Target: $82 → $92
Current: $206.93
Upside: n/a
Aug 1, 2023
Rated: Buy
Price Target: $105
Current: $162.06
Upside: n/a
Jul 28, 2023
Rated: Hold
Price Target: $63 → $61
Current: $104.01
Upside: n/a
Jul 27, 2023
Maintained: Hold
Price Target: $300
Current: $372.13
Upside: n/a
Jul 27, 2023
Rated: Buy
Price Target: $375
Current: $190.86
Upside: n/a
Jul 27, 2023
Rated: Hold
Price Target: $142
Current: $145.17
Upside: n/a
Jul 25, 2023
Maintained: Buy
Price Target: $33 → $32
Current: $19.79
Upside: n/a
Jul 14, 2023
Maintained: Buy
Price Target: $565
Current: $399.47
Upside: n/a
Jul 12, 2023
Maintained: Buy
Price Target: $100 → $86
Current: $62.33
Upside: n/a
Jun 29, 2023
Rated: Hold
Price Target: $1 → $2
Current: $25.84
Upside: n/a
May 3, 2023
Maintained: Sell
Price Target: $35 → $34
Current: $36.05
Upside: n/a
Mar 2, 2022
Maintained: Hold
Price Target: $45 → $30
Current: $0.674
Upside: n/a
Mar 1, 2022
Maintained: Hold
Price Target: $22 → $16
Current: $1.73
Upside: n/a
Feb 8, 2022
Maintained: Hold
Price Target: $9 → $5
Current: $0.8792
Upside: n/a
Aug 12, 2021
Upgraded: Buy
Price Target: $26 → $19
Current: $7.30
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $19 → $15
Current: $6.68
Upside: n/a
Aug 3, 2021
Maintained: Sell
Price Target: $6 → $10
Current: $2.74
Upside: n/a
Feb 25, 2021
Maintained: Hold
Price Target: $23 → $33
Current: $2.70
Upside: n/a
Jan 15, 2021
Maintained: Buy
Price Target: $105 → $135
Current: $192.16
Upside: n/a
Jun 30, 2017
Downgraded: Sell
Price Target: n/a
Current: $9.11
Upside: n/a
May 15, 2017
Initiated Coverage: Hold
Price Target: $19 → $14
Current: $5.00
Upside: n/a
Mar 16, 2017
Upgraded: Hold
Price Target: n/a
Current: $200.29
Upside: n/a
Sep 17, 2013
Initiated Coverage: Hold
Price Target: $49
Current: $181.34
Upside: n/a
Sep 17, 2013
Initiated Coverage: Buy
Price Target: $50
Current: $149.45
Upside: n/a